Skip to main content
. 2017 Jan 31;8(26):42020–42029. doi: 10.18632/oncotarget.14923

Table 2A. Dosimetric results of IMRT, VMAT and TOMO for planning dosimetric parameters and organs at risk.

Variable IMRT VMAT TOMO
Mean ± SD
Supine Prone Supine Prone Supine Prone
D97 (PTV48.89) 98.62±1.12 98.39±0.95 99.02±1.16 99.47±0.60 98.94±1.03 99.21±0.71
Hot spot(Gy) 53.95±0.78 53.52±0.93 53.33±0.70 53.84±0.90 49.76±13.65 53.50±0.76
CI 0.81±0.04 0.76±0.08 0.85±0.04 0.80±0.08 0.89±0.05 0.88±0.13
HI 1.07±0.02 1.06±0.02 1.06±0.02 1.05±0.01 1.04±0.02 1.05±0.01
Small bowelDmax (Gy) 45.32±12.04 41.49±9.88 45.16±12.04 41.54±10.53 44.70±11.84 39.81±9.08
BladderDmax (Gy) 50.39±1.95 50.00±1.27 50.59±2.49 50.16±4.43 48.36±4.71 50.00±3.47
Mean dose (Gy) 29.30±5.75 32.35±5.58 26.66±6.77 26.77±6.78 21.10±5.68 22.24±9.63
V30 (%) 45.81±23.42 57.41±31.58 39.19±19.73 38.87±25.04 14.27±11.17 31.75±29.50
V34.98 (%) 28.98±18.67 40.67±25.77 24.45±15.77 28.95±21.85 3.90±5.67 8.03±12.46
V40 (%) 17.04±11.65 25.37±19.24 17.01±11.95 19.34±19.46 7.07±7.08 13.97±19.18
V44.87 (%) 5.93±6.14 9.04±7.52 7.53±6.40 9.16±8.18 3.90±5.67 8.03±12.46
V48.07 (%) 1.70±2.56 2.05±2.69 2.20±2.86 2.70±3.16 1.64±3.77 1.43±2.72
V50 (%) 0.83±1.72 0.36±0.66 0.71±1.40 0.92±1.58 0.99±2.75 3.32±6.32
Femoral headMean dose (Gy) 27.60±3.91 26.05±8.67 28.47±4.25 28.49±4.71 21.38±9.87 17.96±10.20
V30 (%) 37.10±20.65 37.38±40.78 41.65±31.38 38.55±24.51 10.08±7.44 12.26±10.05
V40 (%) 3.62±3.36 6.98±14.00 3.77±4.24 5.99±10.52 0.43±0.66 2.29±5.12

D97: the percentage of the prescribed dose covering 97% volume of PTV; IMRT: intensity modulated radiation therapy; PTV48.89: planning target volume 48.89 Gy; SD: standard deviation; VMAT: volumetric modulated radiation therapy; TOMO: helical tomotherapy; Vx: the percentage of organ receiving more or equal to x Gy.